![David Neil Hayes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Neil Hayes
Founder at GeneCentric Therapeutics, Inc.
David Neil Hayes active positions
Companies | Position | Start | End |
---|---|---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Director/Board Member | - | - |
Founder | 31/12/2010 | - | |
North Carolina Cancer Hospital
![]() North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Corporate Officer/Principal | - | - |
Career history of David Neil Hayes
Training of David Neil Hayes
The University of North Carolina at Charlotte | Doctorate Degree |
Davidson College | Undergraduate Degree |
Harvard T.H. Chan School of Public Health | Graduate Degree |
Statistics
International
United States | 6 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
GeneCentric Therapeutics, Inc.
![]() GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
North Carolina Cancer Hospital
![]() North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Health Services |
- Stock Market
- Insiders
- David Neil Hayes
- Experience